Cybin Inc.: Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024

- Amir Inamdar, Chief Medical Officer, to appear on panel discussions on June 5 and June 8 - - Ellen James, Director, Clinical Development, to present abstract titled "SPL026 (DMT fumarate) in combination

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,United Kingdom ,United States ,Canada ,Haarlem ,Ireland ,American ,Kellen James ,Gabriel Fahel ,Samir Inamdar ,Exchange Commission ,Health Canada ,Linkedin ,Youtube ,Instagram ,Clinical Development ,Interdisciplinary Conference On Psychedelic Research ,Drug Administration ,Cybin Inc ,Chief Medical Officer ,Major Depressive ,Interdisciplinary Conference ,Psychedelic Research ,Marketing Approval ,Psychedelics Designing Trials ,Access Summit ,Chief Medical ,Major Depressive Disorder ,Generalized Anxiety Disorder ,Breakthrough Therapy Designation ,Cboe Canada ,Legal Officer ,Ihr Portfolio ,